The company says its machine learning approach could help flag cardiac amyloidosis from standard 12-lead ECGs, though experts ...
CHICAGO--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care, today announced the impact of a new decision by ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results